The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2014
Filed:
Sep. 13, 2012
Andreas Meinke, Pressbaum, AT;
Eszter Nagy, Vienna, AT;
Uwe Von Ahsen, Vienna, AT;
Christoph Klade, Wr. Neustadt, AT;
Tamas Henics, Vienna, AT;
Wolfgang Zauner, Vienna, AT;
Duc Bui Minh, Vienna, AT;
Oresta Vytvytska, Vienna, AT;
Hildegard Etz, Vienna, AT;
Agnieszka Dryla, Vienna, AT;
Thomas Weichhart, Boheimkirchen, AT;
Martin Hafner, Vienna, AT;
Brigitte Tempelmaier, Vienna, AT;
Claire M. Fraser, Potomac, MD (US);
Steven Gill, Frederick, MD (US);
Andreas Meinke, Pressbaum, AT;
Eszter Nagy, Vienna, AT;
Uwe Von Ahsen, Vienna, AT;
Christoph Klade, Wr. Neustadt, AT;
Tamas Henics, Vienna, AT;
Wolfgang Zauner, Vienna, AT;
Duc Bui Minh, Vienna, AT;
Oresta Vytvytska, Vienna, AT;
Hildegard Etz, Vienna, AT;
Agnieszka Dryla, Vienna, AT;
Thomas Weichhart, Boheimkirchen, AT;
Martin Hafner, Vienna, AT;
Brigitte Tempelmaier, Vienna, AT;
Claire M. Fraser, Potomac, MD (US);
Steven Gill, Frederick, MD (US);
Valneva Austria GmbH, Vienna, AT;
Abstract
Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to auto-immunity, said antigens being suited for use in a vaccine for a given type of animal or for humans, which is characterized by the following steps: providing an antibody preparation, providing at least one expression library, identifying antigens which bind, screening the identified antigens, identifying the hyperimmune serum-reactive antigen portion of said identified antigens and which hyperimmune serum-reactive antigens bind to a relevant portion of said individual antibody optionally isolating said hyperimmune serum-reactive antigens and producing said hyperimmune serum-reactive antigens by chemical or recombinant methods.